Tiago Girao
CIK 1618670 · Chief Financial Officer · last filed 2026-04-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$8.32M
Companies
3
Total Filings
20
Lifetime Open-Market Net
-$729.9K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IMVT | Chief Financial Officer | 247,596 | $33.62 | $8.32M | -$763.0K | 3 | 2026-04-24 |
| Landos Biopharma, Inc. (LABP) Delisted | Director | — | $22.93 | — | $0 | 5 | 2024-05-23 |
| PLUS THERAPEUTICS, INC. (CYTX) Delisted | VP & Chief Financial Officer | 14,084 | — | — | $33.1K | 11 | 2017-11-29 |
Recent Filings · Page 2 of 2
20 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-03-17 | PLUS THERAPEUTICS, INC. (CYTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-03-10 | PLUS THERAPEUTICS, INC. (CYTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-06-15 | PLUS THERAPEUTICS, INC. (CYTX) Delisted | Exer (X) | +5,667 | $0 | EDGAR |
| 2016-02-05 | PLUS THERAPEUTICS, INC. (CYTX) Delisted | Grant (A) | +35,250 | $0 | EDGAR |
| 2016-02-01 | PLUS THERAPEUTICS, INC. (CYTX) Delisted | Grant (A) | +35,250 | $0 | EDGAR |
| 2016-01-04 | PLUS THERAPEUTICS, INC. (CYTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-08-19 | PLUS THERAPEUTICS, INC. (CYTX) Delisted | Buy (P) | +25,000 | $9.8K | EDGAR |
| 2015-02-03 | PLUS THERAPEUTICS, INC. (CYTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-11-12 | PLUS THERAPEUTICS, INC. (CYTX) Delisted | Buy (P) | +60,000 | $23.4K | EDGAR |
| 2014-09-04 | PLUS THERAPEUTICS, INC. (CYTX) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–20 of 20
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.